Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2351)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (101)
  6. Guidelines (40)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4749)
  2. Department of Medicine (4747)
  3. Center for Pancreatic Cancer Research (2316)
  4. Surgery (1067)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (843)

More Groups

People
  1. Eileen O'Reilly (804)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (224)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (322)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4749)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric cancer (mGC) with or without prior gastrectomy: Results from a phase III study (TAGS)
    Meeting Abstract

    Ilson, D. H.; Prokharau, A.; Arkenau, H. T.; Ghidini, M.; Fujitani, K.; Van Cutsem, E.; Thuss-Patience, P. C.; Beretta, G. D.; Mansoor, W.; Zhavrid, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic chemo (CTX) plus surgery and intraperitoneal (IP) CTX for patients (pts) with gastric cancer (GC) and peritoneal carcinomatosis (PC)
    Meeting Abstract

    Greally, M.; Strong, V. E.; Yoon, S. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second -line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA)
    Meeting Abstract

    Greally, M.; Jha, S.; Yoon, S. S.; Li, J.; Desai, A. M.; Won, E.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Aljallad, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A retrospective study of hepatic arterial infusion (HAI) FUDR/Dex and mitomycin C (MMC) for chemotherapy refractory unresectable intrahepatic cholangiocarcinomas (ICC)
    Meeting Abstract

    Dos Santos Fernandes, G.; Kemeny, N. E.; Hauser, H.; Harding, J. J.; Boerner, T.; Varghese, A. M.; Kingham, P.; D'Angelica, M. I.; DeMatteo, R. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MORPHEUS: A phase Ib/II study platform evaluating the safety and clinical efficacy of cancer immunotherapy (CIT)-based combinations in gastrointestinal (GI) cancers
    Meeting Abstract

    Desai, J.; Kortmansky, J. S.; Segal, N. H.; Fakih, M.; Oh, D. Y.; Kim, K. P.; Rahma, O. E.; Ko, A. H.; Chung, H. C.; Alsina, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review
    Meeting Abstract

    Chan, D.; Bergsland, E. K.; Chan, J. A.; Gadgil, R.; Halfdanarson, T. R.; Hornbacker, K.; Kelly, V.; Kunz, P. L.; McGarrah, P. W.; Raj, N. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Predictors of treatment response in colorectal high-grade neuroendocrine carcinomas (HGNEC): A single institution experience
    Meeting Abstract

    Corbett, V.; Raj, N. P.; Kelly, V.; Reidy, D. L.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Quality-adjusted life years assessment using cabozantinib for patients with advanced hepatocellular carcinoma (aHCC) in the CELESTIAL trial
    Meeting Abstract

    Abou-Alfa, G. K.; Mollon, P.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Kelley, R. K.; Baron, A. D.; Benzaghou, F.; Valcheva, V. V.; Hazra, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Trial design for a phase 3 study evaluating pemigatinib (INCB054828) versus gemcitabine plus cisplatin chemotherapy in first-line treatment of patients with cholangiocarcinoma with FGFR2 rearrangement
    Meeting Abstract

    Bekaii-Saab, T. S.; Valle, J. W.; Borad, M. J.; Melisi, D.; Vogel, A.; FeĢliz, L.; Lihou, C. F.; Zhen, H.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save